Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Centre de Médecine Métabolique de Lanaudière (CMML) is a specialized medical clinic and research center focusing on metabolic diseases, especially obesity, diabetes, and related liver conditions. The clinic offers both clinical care and participates in phase 3 clinical trials for novel metabolic therapies, including peptide-based and small molecule drugs. The team includes specialist physicians, nurses, dietitians, and kinesiologists, providing multidisciplinary care. CMML is actively involved in clinical research to advance treatment options in metabolic health, and medical services are covered by the Quebec health insurance plan (RAMQ), while some services are private.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centre de Médecine Métabolique de Lanaudière.